DT
VRTX icon

Diversified Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Diversified Trust’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Buy
2,067
+1,336
+183% +$592K 0.02% 498
2026
Q1 		$326K Buy
731
+70
+11% +$32.6K 0.01% 823
2025
Q4 		$300K Buy
661
+50
+8% +$21.6K 0.01% 834
2025
Q3 		$239K Sell
611
-2
-0.3% -$836 ﹤0.01% 868
2025
Q2 		$273K Sell
613
-19
-3% -$8.76K 0.01% 780
2025
Q1 		$306K Buy
632
+95
+18% +$44.3K 0.01% 724
2024
Q4 		$216K Sell
537
-491
-48% -$228K 0.01% 831
2024
Q3 		$479K Sell
1,028
-522
-34% -$251K 0.01% 597
2024
Q2 		$727K Buy
1,550
+95
+7% +$41.2K 0.02% 430
2024
Q1 		$608K Sell
1,455
-493
-25% -$208K 0.02% 461
2023
Q4 		$793K Buy
1,948
+17
+0.9% +$6.28K 0.03% 358
2023
Q3 		$671K Sell
1,931
-454
-19% -$159K 0.03% 363
2023
Q2 		$839K Buy
2,385
+786
+49% +$265K 0.03% 323
2023
Q1 		$504K Sell
1,599
-721
-31% -$216K 0.02% 458
2022
Q4 		$670K Buy
2,320
+553
+31% +$169K 0.03% 348
2022
Q3 		$512K Buy
1,767
+497
+39% +$143K 0.02% 383
2022
Q2 		$358K Sell
1,270
-1,395
-52% -$373K 0.02% 513
2022
Q1 		$695K Buy
2,665
+46
+2% +$10.9K 0.02% 347
2021
Q4 		$575K Sell
2,619
-535
-17% -$104K 0.02% 410
2021
Q3 		$572K Sell
3,154
-489
-13% -$95.5K 0.02% 361
2021
Q2 		$735K Buy
3,643
+337
+10% +$70.5K 0.03% 297
2021
Q1 		$710K Buy
3,306
+107
+3% +$23.5K 0.03% 279
2020
Q4 		$756K Hold
3,199
– – 0.03% 254
2020
Q3 		$871K Buy
3,199
+1,232
+63% +$340K 0.04% 207
2020
Q2 		$571K Buy
1,967
+330
+20% +$89.5K 0.03% 238
2020
Q1 		$390K Buy
1,637
+11
+0.7% +$2.52K 0.02% 253
2019
Q4 		$356K Buy
+1,626
New +$329K 0.02% 304

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Diversified Trust's VRTX Position: Q2 2026 in Review

Diversified Trust increased its Vertex Pharmaceuticals (VRTX) stake by 183% in Q2 2026, buying an estimated $592K and bringing the position to 2,067 shares worth $1.03M. The position accounts for 0.02% of the portfolio, ranked #498.

Diversified Trust first reported a position in VRTX in Q4 2019 and has held it in 27 quarters since. 330 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Diversified Trust held 2,067 shares of Vertex Pharmaceuticals worth $1.03M as of Q2 2026.
  • Diversified Trust bought 1,336 Vertex Pharmaceuticals shares in Q2 2026, an estimated $592K.
  • Vertex Pharmaceuticals made up 0.02% of Diversified Trust's portfolio in Q2 2026, its #498 holding.
  • Diversified Trust first reported a position in Vertex Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • 330 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.